Then, to verify whether PD-L2 is correlated to bladder cancer cell migration and invasion, CRISPR PD-L2 knockout 253J-BV and PD-L2 OE 253J sublines were established for further studies (Fig. 4G). The gene discussed is PDCD1LG2; the disease is urinary bladder cancer.